ADVFN - Advanced Financial Network.
HOME» NYSE » P » PFE Stock Price » PFE Stock News

Pfizer Share News

 Pfizer Stock Price
PFE Stock Price
 Pfizer Stock Chart
PFE Stock Chart
 Pfizer Stock News
PFE Stock News
 Pfizer Company Information
PFE Company Information
 Pfizer Stock Trades
PFE Stock Trades

WSJ BLOG/Health: A.M. Vitals: NFL Retirees File Suit on Head Injuries

(This story has been posted on The Wall Street Journal Online's Health Blog at By Stefanie Ilgenfritz Here's what's making health news this morning: NFL Retirees File Single Suit for Head Injuries (WSJ): In the complaint, lawyers for more than 2,300 retired players in 86 suits alleged that for decades the NFL hid the risks of such injuries and ignored mounting evidence of the long-term effects that football-related concussions can have, including dementia and chronic depression. Pfizer Prepares for IPO of Animal Health Unit (WSJ): The New York drug maker also disclosed a new name for the animal-health business, Zoetis, which Pfizer said is based on the root "zo" found in animal-related words such as zoo and zoology. Former Coke Executive Slams 'Share of Stomach' Marketing Campaign (Washington Post): Todd Putnam, a former marketing executive at Coca-Cola, now regrets his work and says it contributed to the nation's obesity problem. 6.6 Million Young Adults on Parents' Health Plans, Survey Says (LA Times): That number, found in a survey by the nonprofit Commonwealth Fund, is far higher than earlier estimates. Arizona Tries to Keep Reins Tight as It Starts Regulating Medical Marijuana (NY Times): In Arizona, dispensaries have to abide by zoning regulations that change from one municipality to the next; applicants must offer detailed plans on how to secure, store and track the marijuana; and they have to offer educational materials and hire a medical director to supervise. Suicide Among U.S. Troops Averaging One a Day in 2012 (USA Today): The 154 suicides for active-duty troops in the first 155 days of the year far outdistance the U.S. forces killed in action in Afghanistan -- about 50% more -- according to Pentagon statistics obtained by the Associated Press. -For continuously updated news from The Wall Street Journal, see at

Stock News for Pfizer (PFE)
04/29/201604:50:00AstraZeneca's Investment Eats Into Profit
04/28/201612:00:00Pfizer Hosts Annual Meeting of Shareholders
04/26/201608:30:00Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled
04/22/201618:30:00CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global C...
04/21/201614:00:00Pfizer Invites Public to Listen to Webcast of April 28 Annual...
04/19/201608:00:00Pfizer Announces Positive Top-Line Results for Phase 3 PALOMA-2...
04/18/201617:36:10Statement of Changes in Beneficial Ownership (4)
04/18/201617:36:10Statement of Changes in Beneficial Ownership (4)
04/18/201617:36:10Statement of Changes in Beneficial Ownership (4)
04/18/201617:35:43Statement of Changes in Beneficial Ownership (4)
04/15/201611:16:23Additional Proxy Soliciting Materials (definitive) (defa14a)
04/15/201606:00:00On the Latest BizWireTV Cars Get Night Vision and Healthy Eating...
04/07/201610:47:00A.M. Best Affirms Ratings of Blue Whale Re Ltd.
04/07/201609:00:00Allergan Completes Licensing Deal After Pfizer Bid Collapses
04/07/201608:49:00Allergan Completes Licensing Deal After Pfizer Bid Collapses
04/07/201608:30:00Pfizer Taps IBM for Research Collaboration to Transform Parkinson’s D...
04/07/201604:50:00Global Stocks Mostly Edge Up After Oil Price Rally
04/07/201604:42:00Global Stocks Mostly Edge Up After Oil Price Rally
04/06/201620:11:00Pfizer, Allergan to Hunt for Deals of Their Own
04/06/201618:30:00FDA Approves Medtronic Device, Billed as World's Smallest Pacemaker

Pfizer and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations